Outlook Therapeutics shareholders approve increase in authorized common shares to 600 million
OTLK•Shareholders approve charter amendment and related authorizations
- Outlook Therapeutics shareholders met July 16, 2026, backing a charter amendment to raise authorized common shares to 600 million from 260 million.
- The authorized-share increase was executed the same day through a filed certificate of amendment, effective July 16, 2026.
- Shareholders also cleared potential share issuance tied to April 2026 private placement warrants and placement agent warrants covering up to 18,387,097 shares.
- A separate authorization passed for potential share issuance from amended, previously issued warrants covering up to 2,142,854 shares.
- Shareholders also approved a reverse stock split range of 1-for-10 to 1-for-50, with the final ratio left to the board.
